George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 994.00
Bid: 992.00
Ask: 994.00
Change: 11.00 (1.12%)
Spread: 2.00 (0.202%)
Open: 967.00
High: 1,000.00
Low: 967.00
Prev. Close: 983.00
DNLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

B/C SHARE SCHEME - PURCHASE OF C SHARES

11 Mar 2015 17:55

RNS Number : 2189H
Dunelm Group plc
11 March 2015
 



 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

 

Dunelm Group plc

 

(the 'Company')

 

11 March 2015

 

B/C SHARE SCHEME - PURCHASE OF C SHARES

 

 

Following the purchase by UBS Limited, acting as principal (and not as agent, nominee or trustee), from Shareholders of 73,756,725 C Shares pursuant to the Purchase Offer (as announced earlier today by the Company), such C Shares have today subsequently been purchased by the Company from UBS Limited pursuant to the Option Agreement.

 

The price paid by the Company to UBS Limited for this purchase was 70 pence per C Share. The Company has also reimbursed any stamp duty or stamp duty reserve tax paid by UBS Limited as a result of its purchase of the C Shares pursuant to the Purchase Offer. The total amount paid was therefore £ 51,887,856.04.The purchased C Shares will be cancelled by the Company.

 

UBS Limited has today also purchased, for an aggregate consideration of one penny, the Deferred Shares arising on the automatic reclassification of the 128,710,152 B Shares in respect of which the B Share Dividend is payable. Pursuant to the terms of the Option Agreement as described in the circular published by the Company on 12 February in relation to the B/C Share Scheme (the 'Circular'), the Company has today purchased these Deferred Shares from UBS Limited for an aggregate consideration of one penny. Those purchased Deferred Shares will be cancelled by the Company.

 

It is expected that Shareholders entitled to receive the proceeds of sale of their C Shares to UBS Limited will be sent cheques or, if mandate instructions are held in respect of a Sterling bank account, that payments will be made by BACS to mandated accounts by 24 March 2015.

 

Unless the context otherwise requires, capitalised terms used in this announcement shall have the same meaning ascribed to them in the Circular.

 

 

Enquiries:

 

 

Dunelm Group plc 0116 2644 356

Will Adderley, Chief Executive

David Stead, Finance Director

MHP Communications 020 3128 8100

John Olsen

Simon Hockridge

Naomi Lane

 

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any security, nor the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in any jurisdiction in contravention of applicable law.

 

None of the B Shares, the C Shares or the Deferred Shares have been or will be registered under the US Securities Act or the state securities laws of the United States and none of them may be offered or sold in the United States unless pursuant to a transaction which has been registered under the US Securities Act and/or relevant state securities laws or which is not subject to the registration requirements of the US Securities Act or such laws, either because of an exemption therefrom or otherwise.

 

None of the B Shares, the C Shares or the Deferred Shares or this announcement or the Circular has been approved, disapproved or otherwise recommended by any US federal or state securities commission or other regulatory authority or any non-US securities commission or regulatory authority nor have any such authorities confirmed the accuracy or determined the adequacy of this announcement or the Circular. Any representation to the contrary is a criminal offence in the United States.

 

UBS Limited is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority and is acting as financial adviser to Dunelm in connection with the Return of Capital and for no one else and will not be responsible to anyone other than Dunelm (whether or not a recipient of this announcement of the Circular) for providing the protections afforded to clients of UBS Limited nor for providing advice in relation to the proposals described in this announcement or the Circular or any other matter referred to in this announcement or the Circular. Persons other than Dunelm are recommended to seek their own financial and professional advice.

 

Apart from the responsibilities and liabilities, if any, which may be imposed on UBS Limited by the FSMA or the regulatory regime established thereunder, UBS Limited accepts no responsibility or liability whatsoever for the contents of this announcement or the Circular or for any other statement made or purported to be made in connection with the Company or the proposed Return of Capital. UBS Limited accordingly disclaims all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which it might otherwise have in respect of this announcement, the Circular or any such statement.

 

This announcement has been issued by, and is the sole responsibility of, the Company.

 

Name of authorised Company official responsible for making this notification:

 

Dawn Durrant, Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDFLFFEXFZBBV
Date   Source Headline
18th Apr 20247:00 amRNSThird quarter trading update
15th Apr 202410:00 amRNSBlock Listing Six Monthly Return
15th Apr 20247:00 amRNSDirector Declaration
28th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 202410:45 amRNSDirectorate Change
29th Feb 20247:00 amRNSTotal Voting Rights
14th Feb 20243:31 pmRNSRecord date for dividend – Correction
14th Feb 20247:00 amRNSInterim Results
8th Feb 20247:00 amRNSDirectorate Changes
31st Jan 20247:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSSecond quarter and first half trading update
11th Jan 20241:00 pmRNSDirectorate Change
29th Dec 20237:00 amRNSTotal Voting Rights
8th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 202311:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSTotal Voting Rights
21st Nov 20233:30 pmRNSDirector/PDMR Shareholding
16th Nov 20231:30 pmRNSResults of AGM
15th Nov 20237:00 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNS'At Home with Dunelm' event
2nd Nov 202312:30 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
19th Oct 202310:13 amRNSAnnual report and accounts and Notice of AGM
19th Oct 20237:00 amRNSFirst quarter trading update
9th Oct 20237:00 amRNSBlock Listing Six Monthly Return
29th Sep 20237:00 amRNSTotal Voting Rights
20th Sep 20237:00 amRNSPreliminary Results
31st Aug 20237:00 amRNSTotal Voting Rights
31st Jul 20237:00 amRNSTotal Voting Rights
20th Jul 20237:00 amRNSQ4 and full year trading update
30th Jun 20237:00 amRNSTotal Voting Rights
31st May 202310:00 amRNSTotal Voting Rights
28th Apr 20237:00 amRNSTotal Voting Rights
20th Apr 20237:00 amRNSThird Quarter Trading Update
14th Apr 20237:00 amRNSBlock listing Six Monthly Return
14th Apr 20237:00 amRNSBlock listing Six Monthly Return
14th Apr 20237:00 amRNSBlock listing Six Monthly Return
14th Apr 20237:00 amRNSBlock listing Six Monthly Return
14th Apr 20237:00 amRNSBlock listing Six Monthly Return
31st Mar 20237:00 amRNSTotal Voting Rights
28th Feb 20237:00 amRNSTotal Voting Rights
15th Feb 20237:00 amRNSInterim Results
31st Jan 20237:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSSecond quarter trading update
30th Dec 20227:00 amRNSTotal Voting Rights
12th Dec 202211:10 amRNSHolding(s) in Company
7th Dec 20227:00 amRNSOutcome of audit tender process
1st Dec 20227:00 amRNSTotal Voting Rights
30th Nov 20223:30 pmRNSResults of AGM
30th Nov 20227:00 amRNSConfirmation of Chair Succession

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.